CSIMarket Company Name, Ticker, Competitors, else..
 
Bionexus Gene Lab Corp   (NASDAQ: BGLC)
Other Ticker:  
 
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 
Price: $6.0400 $0.22 3.780%
Day's High: $6.389 Week Perf: -6.07 %
Day's Low: $ 5.68 30 Day Perf: 87.58 %
Volume (M): 185 52 Wk High: $ 15.60
Volume (M$): $ 1,119 52 Wk Avg: $1.13
Open: $5.68 52 Wk Low: $0.21



 Market Capitalization (Millions $) 109
 Shares Outstanding (Millions) 18
 Employees -
 Revenues (TTM) (Millions $) 9
 Net Income (TTM) (Millions $) -1
 Cash Flow (TTM) (Millions $) -4
 Capital Exp. (TTM) (Millions $) 1

Bionexus Gene Lab Corp
Bionexus Gene Lab Corp is a biotechnology company that focuses on genetic research and development. The company specializes in genetic testing, analysis, and sequencing for various applications such as personalized medicine, drug discovery, and agricultural biotechnology. The lab utilizes advanced technologies and techniques to understand genetic variations and their impact on human health and the environment. Bionexus Gene Lab Corp aims to provide valuable insights and innovative solutions through its genetic research to improve health outcomes and promote sustainable practices.


   Company Address: Unit A-28-7, Level 28, Tower A Kuala Lumpur 59000
   Company Phone Number: 241 6898   Stock Exchange / Ticker: NASDAQ BGLC


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
FTRE      % 
A        2.91% 
BIO        2.91% 
ILMN        2.91% 
MRNA        2.91% 
PACB        2.91% 
• View Complete Report
   



Management Announcement

BioNexus Gene Lab Corp. Ventures into Ethereum Treasury Amidst Financial Challenges and Renewable Energy Aspirations

Published Wed, Mar 5 2025 4:01 PM UTC

In a surprising pivot for a company grappling with financial losses, BioNexus Gene Lab Corp. (NASDAQ: BGLC) has made...
Financing Agreement

Biotechnology Meets Renewable Energy: BioNexus Gene Lab Corp Expands Horizons with Protech Builders in Biogas Initiatives

Published Wed, Sep 25 2024 3:32 PM UTC

Biotechnology Meets Renewable Energy: BioNexus Gene Lab Corp. Expands Horizons with Protech Builders in Biogas InitiativesIn a notable convergence of biotechnology and renewable energy sectors, BioNexus Gene Lab Corp. (NASDAQ: BGLC) has formally announced a strategic teaming agreement with Protech Builders Sdn. Bhd. to develop biogas power plants. This partnership signifies ...
Product Service News

BioNexus Gene Lab Corp. Partners with VITARRAY Global to Enhance mRNA Services Amidst Market Challenges

Published Fri, Sep 13 2024 4:05 PM UTC

In a significant development within the biotechnology sector, BioNexus Gene Lab Corp. (NASDAQ: BGLC) has announced a strategic outsourcing agreement with VITARRAY Global Pte. Ltd. a company based in Singapore. The partnership, formalized on September 14, 2024, focuses on providing dynamic mRNA gene detection services tailored to the Southeast Asian market. This collaboration...
Partnership

BioNexus Gene Lab Corp. Forms Strategic Partnership Amidst Stock Struggles

Published Thu, Sep 12 2024 5:23 PM UTC

In a significant move to enhance its offerings in cancer screening, precision medicine, and preventative healthcare, BioNexus Gene Lab Corp. has entered into a strategic partnership with Shenzhen Rongguang Group. This memorandum of understanding (MOU) is poised to bolster innovative healthcare solutions, aiming to capitalize on the growing demand for advanced diagnostic tech...
Financing Agreement

BioNexus Gene Lab Corp Sets the Stage for Growth with Chemrexns Investment in Cutting-Edge Color Paste Production
n,

Published Wed, Sep 11 2024 3:05 PM UTC

nnBioNexus Gene Lab Corp: Strategic Investments and Operational Improvements Position for Future Growthnn
In a notable move that showcases its commitment to growth and innovation, BioNexus Gene Lab Corp (NASDAQ: BGLC) announced on September 11, 2024, that its subsidiary, Chemrex Corporation Sdn. Bhd. (Chemrex), will be pioneering the production of high-quality color past...






Bionexus Gene Lab's Segments
Trading Of Industrial Chemicals    99.86 % of total Revenue
Screening Services And Related Sales    0.14 % of total Revenue
Product And Service    100 % of total Revenue
Malaysia    81.77 % of total Revenue
Maldives    8.47 % of total Revenue
Batam    1.32 % of total Revenue
Singapore    1.6 % of total Revenue
Sri Lanka    6.84 % of total Revenue
Provision For Genomic Screening Services    0.14 % of total Revenue





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com